SAB Biotherapeutics (SABS) Research & Development (2021 - 2026)
SAB Biotherapeutics (SABS) recorded Research & Development of $16.17 million in Q2 2026, up 131.1% from $7 million a year earlier and up 20.7% from the prior quarter.
Powered by 
Analysis
SAB Biotherapeutics (SABS) Research & Development (2021 - 2026) Analysis & Trends
On a TTM basis, SAB Biotherapeutics' Research & Development came in at $49.27 million as of Jun 30, 2026, up 63.5% year-over-year; for FY2025, it came in at $34.35 million, up 13.6% from FY2024.
- Annual Research & Development has a five-year compound annual growth rate of 4.2% (FY2020 to FY2025).
- Across earlier years, Research & Development came in at $30.25 million in FY2024 (+83.2%), $16.52 million in FY2023 (-54.7%), $36.44 million in FY2022 (-36.3%) and $57.18 million in FY2021 (+104.9%).
- The Q2 2026 figure is the highest quarterly Research & Development since Q2 2021.
- On a year-over-year basis, Research & Development has increased for five consecutive quarters, with growth averaging 53.8% over the last eight quarters.
- Peak year-over-year performance for Research & Development in the last five years was growth of 131.1% in Q2 2026, against a decline of 66.0% in Q1 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $13.4 million (Q1 2026), $10.73 million (Q4 2025) and $8.97 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.92 Bn | 1,105.50 Bn | 19.71 Bn | 3.82 Bn |
| 2 | Johnson & Johnson | 617.57 Bn | 536.10 Bn | 17.26 Bn | 3.65 Bn |
| 3 | AbbVie | 501.37 Bn | 474.48 Bn | 12.70 Bn | 2.34 Bn |
| 4 | Merck | 367.96 Bn | 322.33 Bn | 12.21 Bn | 9.74 Bn |
| 5 | Novartis Ag | 297.98 Bn | 261.97 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 261.45 Bn | 235.14 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 236.30 Bn | 191.70 Bn | 7.24 Bn | 1.87 Bn |
| 8 | Gilead Sciences | 190.27 Bn | 164.46 Bn | 6.22 Bn | 1.76 Bn |
| 9 | Pfizer | 169.65 Bn | 116.29 Bn | 10.94 Bn | 2.81 Bn |
| 10 | SAB Biotherapeutics | 228.89 Mn | -188.61 Mn | - | 16.17 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 16.17 Mn |
| Mar 31, 2026 | 13.40 Mn |
| Dec 31, 2025 | 10.73 Mn |
| Sep 30, 2025 | 8.97 Mn |
| Jun 30, 2025 | 7.00 Mn |
| Mar 31, 2025 | 7.66 Mn |
| Dec 31, 2024 | 7.65 Mn |
| Sep 30, 2024 | 7.83 Mn |
| Jun 30, 2024 | 6.82 Mn |
| Mar 31, 2024 | 8.15 Mn |
| Dec 31, 2023 | 4.30 Mn |
| Sep 30, 2023 | 4.02 Mn |
| Jun 30, 2023 | 3.66 Mn |
| Mar 31, 2023 | 4.54 Mn |
| Dec 31, 2022 | 7.14 Mn |
| Sep 30, 2022 | 7.35 Mn |
| Jun 30, 2022 | 8.58 Mn |
| Mar 31, 2022 | 13.32 Mn |
| Dec 31, 2021 | 10.65 Mn |
| Sep 30, 2021 | 15.07 Mn |
API Access
SAB Biotherapeutics Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=SABS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "SABS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=SABS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();